AKR1C3-IN-9 |
Katalog-Nr.GC68633 |
AKR1C3-IN-9 ist ein selektiver Inhibitor der Aldehyd-Keton-Reduktase 1C3 (AKR1C3) mit einer IC50 von 8,92 nM. AKR1C3-IN-9 kehrt signifikant die Doxorubicin (DOX)-Resistenz in resistenten Brustkrebszelllinien um.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
Review for AKR1C3-IN-9
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for AKR1C3-IN-9
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *